ArticlePediatric rheumatology online journal2024

Checkpoint inhibitor immunotherapy induced inflammatory arthritis secondary to Nivolumab and Ipilimumab: a pediatric first.

John A Storwick et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.